EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer

Wei Weng, Jinchun Chen

European Radiology · 19.11.2026

DOI: 10.1007/s00330-026-13085-3 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Radiology, online erschienen am 19.11.2026. Verfasst von Wei Weng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Radiology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Radiology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. shuyi2007@wmu.edu.cn.

Zitieren

APA

Weng, W., & Chen, J. (2026). Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer. European Radiology. https://doi.org/10.1007/s00330-026-13085-3

Vancouver

Weng W, Chen J. Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer. European Radiology. 2026. doi:10.1007/s00330-026-13085-3

BibTeX
@article{Weng2026,
  author = {Weng, Wei and Chen, Jinchun},
  title = {Letter to the Editor: Prognostic stratification should not be equated with adjuvant treatment benefit after neoadjuvant immunotherapy for esophageal cancer},
  journal = {European Radiology},
  year = {2026},
  doi = {10.1007/s00330-026-13085-3}
}
Kostenlos starten →